Philip P Goodney1, Lori L Travis2, Benjamin S Brooke3, Randall R DeMartino3, David C Goodman4, Elliott S Fisher4, John D Birkmeyer4. 1. Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire2Dartmouth-Hitchcock Medical Center, Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire. 2. Center for Outcomes Research and Evaluation, Maine Medical Center, Portland4Center for Health Outcomes and Policy, University of Michigan, Ann Arbor. 3. Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. 4. Dartmouth-Hitchcock Medical Center, Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire.
Abstract
IMPORTANCE: Although lower extremity revascularization is effective in preventing amputation, the relationship between spending on vascular care and regional amputation rates remains unclear. OBJECTIVE: To test the hypothesis that higher regional spending on vascular care is associated with lower amputation rates for patients with severe peripheral arterial disease. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of 18,463 US Medicare patients who underwent a major peripheral arterial disease-related amputation during the period between 2003 and 2010. EXPOSURE: Price-adjusted Medicare spending on revascularization procedures and related vascular care in the year before lower extremity amputation, across hospital referral regions. MAIN OUTCOMES AND MEASURES: Correlation coefficient between regional spending on vascular care and regional rates of peripheral arterial disease-related amputation. RESULTS: Among patients who ultimately underwent an amputation, 64% were admitted to the hospital in the year prior to the amputation for revascularization, wound-related care, or both; 36% were admitted only for their amputation. The mean cost of inpatient care in the year before amputation, including costs related to the amputation procedure itself, was $22,405, but it varied from $11,077 (Bismarck, North Dakota) to $42,613 (Salinas, California) (P < .001). Patients in high-spending regions were more likely to undergo vascular procedures as determined by crude analyses (12.0 procedures per 10,000 patients in the lowest quintile of spending and 20.4 procedures per 10,000 patients in the highest quintile of spending; P < .001) and by risk-adjusted analyses (adjusted odds ratio for receiving a vascular procedure in highest quintile of spending, 3.5 [95% CI, 3.2-3.8]; P < .001). Although revascularization was associated with higher spending (R = 0.38, P < .001), higher spending was not associated with lower regional amputation rates (R = 0.10, P = .06). The regions that were most aggressive in the use of endovascular interventions were the regions that were most likely to have high spending (R = 0.42, P = .002) and high amputation rates (R = 0.40, P = .004). CONCLUSIONS AND RELEVANCE: Regions that spend the most on vascular care perform the most procedures, especially endovascular interventions, in the year before amputation. However, there is little evidence that higher regional spending is associated with lower amputation rates. This suggests an opportunity to limit costs in vascular care without compromising quality.
IMPORTANCE: Although lower extremity revascularization is effective in preventing amputation, the relationship between spending on vascular care and regional amputation rates remains unclear. OBJECTIVE: To test the hypothesis that higher regional spending on vascular care is associated with lower amputation rates for patients with severe peripheral arterial disease. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of 18,463 US Medicare patients who underwent a major peripheral arterial disease-related amputation during the period between 2003 and 2010. EXPOSURE: Price-adjusted Medicare spending on revascularization procedures and related vascular care in the year before lower extremity amputation, across hospital referral regions. MAIN OUTCOMES AND MEASURES: Correlation coefficient between regional spending on vascular care and regional rates of peripheral arterial disease-related amputation. RESULTS: Among patients who ultimately underwent an amputation, 64% were admitted to the hospital in the year prior to the amputation for revascularization, wound-related care, or both; 36% were admitted only for their amputation. The mean cost of inpatient care in the year before amputation, including costs related to the amputation procedure itself, was $22,405, but it varied from $11,077 (Bismarck, North Dakota) to $42,613 (Salinas, California) (P < .001). Patients in high-spending regions were more likely to undergo vascular procedures as determined by crude analyses (12.0 procedures per 10,000 patients in the lowest quintile of spending and 20.4 procedures per 10,000 patients in the highest quintile of spending; P < .001) and by risk-adjusted analyses (adjusted odds ratio for receiving a vascular procedure in highest quintile of spending, 3.5 [95% CI, 3.2-3.8]; P < .001). Although revascularization was associated with higher spending (R = 0.38, P < .001), higher spending was not associated with lower regional amputation rates (R = 0.10, P = .06). The regions that were most aggressive in the use of endovascular interventions were the regions that were most likely to have high spending (R = 0.42, P = .002) and high amputation rates (R = 0.40, P = .004). CONCLUSIONS AND RELEVANCE: Regions that spend the most on vascular care perform the most procedures, especially endovascular interventions, in the year before amputation. However, there is little evidence that higher regional spending is associated with lower amputation rates. This suggests an opportunity to limit costs in vascular care without compromising quality.
Authors: Daniel J Gottlieb; Weiping Zhou; Yunjie Song; Kathryn Gilman Andrews; Jonathan S Skinner; Jason M Sutherland Journal: Health Aff (Millwood) Date: 2010-01-28 Impact factor: 6.301
Authors: Elliott S Fisher; Mark B McClellan; John Bertko; Steven M Lieberman; Julie J Lee; Julie L Lewis; Jonathan S Skinner Journal: Health Aff (Millwood) Date: 2009-01-27 Impact factor: 6.301
Authors: Philip P Goodney; Brian W Nolan; Andres Schanzer; Jens Eldrup-Jorgensen; Andrew C Stanley; David H Stone; Donald S Likosky; Jack L Cronenwett Journal: J Vasc Surg Date: 2009-11-24 Impact factor: 4.268
Authors: Philip P Goodney; Brian W Nolan; Andres Schanzer; Jens Eldrup-Jorgensen; Daniel J Bertges; Andrew C Stanley; David H Stone; Daniel B Walsh; Richard J Powell; Donald S Likosky; Jack L Cronenwett Journal: Ann Vasc Surg Date: 2009-09-11 Impact factor: 1.466
Authors: Elizabeth M Mahoney; Kaijun Wang; David J Cohen; Alan T Hirsch; Mark J Alberts; Kim Eagle; Frederique Mosse; Joseph D Jackson; P Gabriel Steg; Deepak L Bhatt Journal: Circ Cardiovasc Qual Outcomes Date: 2008-09
Authors: Roman Deev; Igor Plaksa; Ilia Bozo; Nina Mzhavanadze; Igor Suchkov; Yuriy Chervyakov; Ilia Staroverov; Roman Kalinin; Artur Isaev Journal: Ther Adv Cardiovasc Dis Date: 2018-07-11
Authors: Thomas F X O'Donnell; Chloe Powell; Sarah E Deery; Jeremy D Darling; Kakra Hughes; Kristina A Giles; Grace J Wang; Marc L Schermerhorn Journal: J Vasc Surg Date: 2018-02-16 Impact factor: 4.268
Authors: Derek J Roberts; Sudhir K Nagpal; Dalibor Kubelik; Timothy Brandys; Henry T Stelfox; Manoj M Lalu; Alan J Forster; Colin Jl McCartney; Daniel I McIsaac Journal: BMJ Date: 2020-11-25
Authors: Brian Witrick; Corey A Kalbaugh; Lu Shi; Rachel Mayo; Brian Hendricks Journal: Int J Environ Res Public Health Date: 2021-12-28 Impact factor: 3.390
Authors: João Paulo Tardivo; Maurício S Baptista; João Antonio Correa; Fernando Adami; Maria Aparecida Silva Pinhal Journal: PLoS One Date: 2015-08-17 Impact factor: 3.240